Triumph Capital Management’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.18K Sell
26
-15
-37% -$3.12K ﹤0.01% 1288
2026
Q1
$8.66K Buy
41
+27
+193% +$5.81K ﹤0.01% 1149
2025
Q4
$2.88K Buy
+14
New +$2.63K ﹤0.01% 1407
2021
Q4
Sell
-4,293
Closed -$214K 214
2021
Q3
$214K Buy
4,293
+546
+15% +$29.6K 0.1% 174
2021
Q2
$214K Buy
+3,747
New +$219K 0.13% 156

Other funds holding CAH

Triumph Capital Management's CAH Position: Q2 2026 in Review

Triumph Capital Management reduced its Cardinal Health (CAH) stake by 37% in Q2 2026, selling an estimated $3.12K and leaving 26 shares worth $6.18K. The position accounts for ﹤0.01% of the portfolio, ranked #1288.

Triumph Capital Management first reported a position in CAH in Q2 2021 and has held it in 5 quarters since. The position peaked at $214K in Q3 2021. 1,500 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Triumph Capital Management held 26 shares of Cardinal Health worth $6.18K as of Q2 2026.
  • Triumph Capital Management sold 15 Cardinal Health shares in Q2 2026, an estimated $3.12K.
  • Cardinal Health made up ﹤0.01% of Triumph Capital Management's portfolio in Q2 2026, its #1288 holding.
  • Triumph Capital Management first reported a position in Cardinal Health in Q2 2021 and has held it in 5 quarters since.
  • Triumph Capital Management's Cardinal Health position peaked at $214K in Q3 2021.
  • 1,500 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Triumph Capital Management's 13F filing for Q2 2026, filed 21 Jul 2026.